PNC Financial Services Group’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-19
Closed 4032
2020
Q3
$0 Hold
19
﹤0.01% 4000
2020
Q2
$1K Buy
+19
New +$1.11K ﹤0.01% 3856
2017
Q3
Sell
-23,204
Closed -$1.64M 4198
2017
Q2
$1.64M Sell
23,204
-2,431
-9% -$157K ﹤0.01% 1072
2017
Q1
$1.66M Buy
+25,635
New +$1.99M ﹤0.01% 1084

Other funds holding NERV

PNC Financial Services Group's NERV Position: Q4 2020 in Review

PNC Financial Services Group sold out of Minerva Neurosciences (NERV) in Q4 2020, closing a stake of 19 shares.

PNC Financial Services Group first reported a position in NERV in Q1 2017 and held it in 4 quarters. The position peaked at $1.66M in Q1 2017. 76 funds tracked by Wall St. Rank hold NERV as of Q4 2020.

  • PNC Financial Services Group reported no remaining Minerva Neurosciences position as of Q4 2020 after selling out during the quarter.
  • PNC Financial Services Group sold 19 Minerva Neurosciences shares in Q4 2020.
  • PNC Financial Services Group first reported a position in Minerva Neurosciences in Q1 2017 and held it in 4 quarters.
  • PNC Financial Services Group's Minerva Neurosciences position peaked at $1.66M in Q1 2017.
  • 76 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2020.

Based on PNC Financial Services Group's 13F filing for Q4 2020, filed 12 Feb 2021.